Take the label off a punnet of mushrooms and what is left is a building, a compost or substrate recipe and a cold route to a shop; this ranking orders companies by how much of that they own rather than by how loudly they sell.
The distinction is not academic. Global mushroom and fungus sales were put at US$70 billion to US$78 billion for 2025, with compound growth forecast above 8% through 2033. Fresh mushrooms keep for roughly seven to fourteen days and the category's average gross margin has sat between 15% and 25%, so the businesses that hold their ground in a price war tend to own the growing rooms, the substrate yard, the processing hall and the trucks: that footprint is what this index measures first.
The first fork in the industry is a fork in the process, and it runs between a bottle and a bed. East Asian producers grow wood-rotting species (enoki, bunashimeji, king oyster and maitake) in high-density bottles or bags stacked on automated multi-tier racks inside numerically controlled rooms, which lifts output per square metre and removes hands from the line. European and North American producers grow Agaricus bisporus on beds in shelf houses, where the moat sits outside the growing room: upstream in one-, two- and three-phase composting, downstream in refrigeration. Monaghan compounds its own compost and casing rather than buying either in, and Monterey runs its farms with a composting front end attached.
The Chinese entrants ride a capacity curve counted in hundreds of thousands of tonnes a year, and almost all of that volume clears inside one country. Shanghai Snowey Bio-Technology works 18 industrialised bases and pushes 1,500 to 1,600 tonnes a day, above 550,000 tonnes a year and the largest enoki capacity anywhere, yet about 98% of revenue is earned at home. Gansu Zongxing Mushroom Technology runs 16 bases at 1,150 tonnes a day (about 750 tonnes of enoki, 400 of button mushrooms) for more than 400,000 tonnes a year and 99% domestic sales. Jiangsu Hualv Bio-Tech, the newest name here, lifted revenue 25.17% to RMB 1.292 billion and doubled net profit to RMB 110 million from six parks, with 98% of sales in China. The exposure is local: Hualv has no overseas capacity to offset a domestic downturn and leans on new parks reaching design output, Zongxing has seen new lines held up by local planning, and Snowey carries heavy depreciation into a market where regional supply and demand swing hard.
On the other curve, tonnage is an order of magnitude smaller and the money is made at the shelf rather than in the tonne. Monaghan moves more than 3,000 tonnes of fresh mushrooms into European retail weekly, takes 85% or more of its revenue in Europe against 12% in North America, and grows over 200,000 tonnes a year. Monterey earns 90% or more of its revenue in North America on over 100,000 tonnes, and Costa supplies more than three quarters of Australia's fresh mushrooms from about 32,000 tonnes. BioFungi is the smallest entrant here at about 25,000 tonnes, drawing 95% or more of its income from organic retailers and processors in Central and Western Europe. Input costs spare nobody: Monaghan absorbs British and European wages and volatile straw and poultry-litter prices, Hokuto higher Japanese electricity and dearer imported woodchips, and Yukiguni Maitake's core EBITDA is squeezed by substrate and freight costs on about 55,000 tonnes of mostly maitake.
A third model barely touches growing rooms at all, and per tonne it may be the most profitable of the three. Scelta Mushrooms processes more than 45,000 tonnes of button mushrooms a year in four plants with around 350 employees, sells into more than 80 countries and takes 22% of revenue in Asia-Pacific, and it earns that money from umami extracts, a mushroom-derived salt replacer and a bagged product that holds twelve months at ambient temperature, taking refrigeration out of a long-haul order. Two consequences follow: the mushrooms Scelta processes are largely bought in, so it carries an upstream price exposure no grower has, and 350 people serving more than 80 markets must satisfy every labelling and food-safety regime along the route. Monterey is moving the same way by doubling capacity at its extraction business, and Yukiguni Maitake has turned its own maitake into a plant-based meat ingredient.
Compliance has moved out of the marketing department and into the capital budget, where it now works as a condition of staying on the shelf. BioFungi runs three organic plants with HEPA air filtration and has switched to a casing that contains no peat at all, a change that raises unit cost long before it returns anything. Monaghan became the first supplier in the United Kingdom to grow supermarket mushrooms on a fully peat-free system, has moved to recyclable paper and bio-based packaging, and holds a five-year agreement with Sainsbury's inside the retailer's £5 billion programme of long-term farm contracts. Costa, its capital freed by the 2024 buyout, has installed 3D-vision picking arms and solar at its Victorian sites, and Hokuto has automated picking too. Monterey spent 24 months getting its spent mushroom compost certified organic, turning a disposal cost into a saleable input.
Ownership decides how much of this page can be checked, and going private means two different things among these ten. Five of the ten publish audited accounts, and every listing sits in Tokyo or Shenzhen: Snowey (300511) and Hualv (300970) on the Shenzhen ChiNext board, Zongxing (002772) on the Shenzhen main board, and Hokuto (1379) with Yukiguni Maitake (1375) on the Tokyo Stock Exchange Prime Market. Costa is the opposite case: taken private in 2024 by a consortium including Paine Schwartz Partners and Driscoll's, it can fund robots and solar without defending a quarter. Monaghan, Scelta and BioFungi were never public, so their figures come down to company statements and named reporting rather than to a filing. VerityRank checks the current Fortune Global 500 list and none of the ten is a Fortune Global 500 member, so the ceiling of 90 points reserved for those members goes unused.
Set side by side, the ten describe a concentrated industry in which the operational risk is concentrated as well. Monterey's closure of its Royal Oaks farm in California cut 605 jobs and moved that volume to other sites, and a ransomware intrusion in August 2025 exposed employee data and drew consolidated class actions by the following quarter. Read a capacity figure as a statement about how many rooms a company can fill rather than a promise about what they earn.
Cultivated Mushroom Owned-Capacity Index
VerityRank scores edible mushroom suppliers against four weighted dimensions:
• Production Strength and Facility Scale (40%): owned growing rooms, automated climate-controlled bases, compost and substrate capacity and daily and annual tonnage.
• Mushroom Production Concentration (25%): the share of output and turnover that is edible mushrooms, fresh or processed, rather than other crops.
• Global Sales and Financial Performance (20%): consolidated revenue for the latest full year, profitability and the markets served.
• Global Brand Influence and Recognition (15%): retail and foodservice listings, export breadth, breeding and patent standing.
The index caps every score at 90, a ceiling reserved for companies that clear the Fortune Global 500 entry line on their own accounts — US$32.2 billion of revenue for the 2025 edition — and unused on this page. No dimension carries less than (10%) of the total, so no company can ride a single strength to the top.
Data Sources
Principal sources include Hokuto's consolidated results for the year ended 31 March 2025, Snowey's 2025 annual report filed in Shenzhen, Sainsbury's long-term farm agreements, the Monterey Nutra capacity announcement, the organic certification of Monterey's spent compost, litigation coverage of the Monterey data breach, the Monaghan Mushrooms company profile, US mushroom crop value reporting and the Fortune Global 500.
Disclaimer: Figures are taken from audited accounts, exchange filings, company publications and reporting that names its source. VerityRank is paid by no company for inclusion, exclusion or position. Amounts appear in each company's own currency with dollar equivalents approximate, and fiscal years end on different dates; several entrants are privately held, and where such a company publishes nothing this page says so. Estimates are attributed to the publisher that made them, no score is transferred from a parent, an owner or a licensor, and the Fortune Global 500 list is checked directly rather than inferred from revenue. Volume packed or traded for another business rather than produced by the company itself is not credited as its own output, distinct from the operating revenue of the company being scored.